1. Home
  2. Labeler Index
  3. Denton Pharma, Inc. Dba Northwind Pharmaceuticals
  4. 70934-662
  5. Product Images: Aripiprazole

Product Images Aripiprazole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Aripiprazole NDC 70934-662 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

label - 70934 662 30 Master Bottle Label Approval Rev A 04 20

label - 70934 662 30 Master Bottle Label Approval Rev A 04 20

This is a description of a medicine called Aripiprazole Tablets, USP 5mg. The package contains 30 tablets and has an NDC number of 70934-662-30. The medicine is a prescription drug and can only be obtained through a doctor. There is also some information about the manufacturer of the medicine.*

Figure 1 - aripiprazole figure 1

Figure 1 - aripiprazole figure 1

This appears to be a table or chart showing the effect of various drugs on the pharmacokinetics of aripiprazole. The drugs are categorized as CYP3A inhibitors, CYP2D6 inhibitors, gastric acid blockers, and others. The table shows the percent change and confidence interval in the PK (pharmacokinetics) of aripiprazole when taken with each specific drug compared to when taken alone. It appears to be a reference for healthcare professionals to understand potential drug interactions with aripiprazole.*

Figure 2 - aripiprazole figure 2

Figure 2 - aripiprazole figure 2

This appears to be a table or graph showing the effects of various drugs on aripiprazole. The drugs listed include gastric acid blockers, valproate, and ocazapm. The table shows a percentage change relative to a reference without interacting drugs. More specific information on the purpose and results of this study cannot be determined from this text alone.*

Figure 3 - aripiprazole figure 3

Figure 3 - aripiprazole figure 3

Figure 4 - aripiprazole figure 4

Figure 4 - aripiprazole figure 4

This appears to be a chart or table related to special populations in a study or experiment. The text includes information regarding gender, hepatic impairment, and renal impairment. There is also data related to "Aviiprazcie Fod Change" which is unclear without additional context. However, without further information, it is not possible to provide a more detailed description or interpretation.*

Figure 5 - aripiprazole figure 5

Figure 5 - aripiprazole figure 5

Figure-6 - aripiprazole figure 6

Figure-6 - aripiprazole figure 6

Figure-7 - aripiprazole figure 7

Figure-7 - aripiprazole figure 7

Figure-8 - aripiprazole figure 8

Figure-8 - aripiprazole figure 8

The given text seems to be a table presenting the number of subjects at risk and the proportion with relapse with regards to the medication named "ARFPRAZOLE". It appears that the table has columns for different time periods and corresponding values. It may be related to a clinical trial or study.*

aripiprazole chemical structure - aripiprazole structure

aripiprazole chemical structure - aripiprazole structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.